UNC Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.
UNC Chapel Hill has participated in 127 clinical trials with 32 currently active.
Therapeutic areas: Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma.
Sponsors: Guardant Health, Inc., Duke University, Arginox Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UNC Chapel Hill has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UNC Chapel Hill has 127 clinical trials on record, with 32 currently active. Their work covers Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma.
UNC Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.